Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nasdaq Biotechnology Ishares ETF (IBB)

Nasdaq Biotechnology Ishares ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 7,125,440,000
  • Market Capitalization, $K 7,125,440
  • Shares Outstanding, K 64,000
  • 60-Month Beta 1.36
  • Price/Earnings ttm 20.33
  • Annual Dividend & Yield 0.15 (0.14%)
  • Most Recent Dividend 0.071 on 09/24/19
  • Management Fee 0.47%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
102.43 +11.68%
on 10/21/19
114.63 -0.21%
on 11/20/19
+12.12 (+11.85%)
since 10/18/19
3-Month
96.03 +19.12%
on 10/02/19
114.63 -0.21%
on 11/20/19
+9.31 (+8.86%)
since 08/20/19
52-Week
89.01 +28.51%
on 12/24/18
116.25 -1.60%
on 03/04/19
+12.21 (+11.95%)
since 11/20/18

Most Recent Stories

More News
Top-Ranked ETFs That Crushed the Market in a Month

The latest rally has been broad based with many corners of the space generating above-market returns over a month.

FXR : 44.54 (-0.49%)
XSD : 98.12 (-0.81%)
IBB : 114.04 (+0.52%)
JSML : 45.47 (-0.20%)
RDVY : 34.38 (-0.35%)
SPVU : 37.57 (-0.34%)
Follow Morgan Stanley to Trade 2020 Election With ETFs

Morgan Stanley outlined four outcomes of the 2020 election and its strategies for investors on how to make the most of them.

XBI : 87.50 (+0.33%)
IYT : 193.74 (-0.66%)
XTN : 64.09 (-0.41%)
QCLN : 22.63 (-0.40%)
PBW : 30.49 (-0.55%)
IBB : 114.04 (+0.52%)
XLV : 97.63 (-0.16%)
OIH : 11.60 (+3.11%)
XOP : 21.02 (+2.09%)
KRE : 55.80 (-0.11%)
IAT : 49.36 (unch)
EEM : 43.08 (-0.16%)
XLE : 59.40 (+1.59%)
VHT : 182.52 (+0.01%)
KBWB : 56.01 (-0.28%)
KB : 39.16 (+1.40%)
Zacks Market Edge Highlights: XLK, IBB, Square, SOXX and Amazon

Zacks Market Edge Highlights: XLK, IBB, Square, SOXX and Amazon

AMZN : 1,753.81 (+0.06%)
SQ : 67.33 (+1.45%)
SOXX : 234.52 (-0.28%)
IBB : 114.04 (+0.52%)
XLK : 87.50 (-0.19%)
Our Favorite Investing Lessons from the Last 20 Years

On this special 200th episode of the podcast, Tracey Ryniec and Kevin Cook reveal the top lessons they've learned from decades of investing.

AMZN : 1,753.81 (+0.06%)
SQ : 67.33 (+1.45%)
SOXX : 234.52 (-0.28%)
XLK : 87.50 (-0.19%)
IBB : 114.04 (+0.52%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 53.16 (+0.45%)
IBB : 114.04 (+0.52%)
XBI : 87.50 (+0.33%)
CELG : 107.64 (-0.45%)
VRTX : 215.13 (+0.06%)
BIIB : 287.76 (+0.82%)
Biotech ETFs in Focus on Impressive Q3 Earnings Results

Let's take a look at some ETFs with wide exposure to a few biotechnological companies which released solid Q3 earnings results recently.

BMY : 55.62 (-1.52%)
FBT : 140.03 (+1.06%)
IBB : 114.04 (+0.52%)
XBI : 87.50 (+0.33%)
BBH : 136.11 (+0.44%)
AMGN : 224.59 (+0.04%)
BIIB : 287.76 (+0.82%)
CELG : 107.64 (-0.45%)
ALXN : 109.95 (-0.63%)
GILD : 65.13 (+0.20%)
Navigating The Healthcare Industry: Science Fiction Turns to Reality

Kevin Cook joins us to help walk us through the maze that is the healthcare industry. We touch on everything from the hottest trends all the way down to how to pick a winning stock!

IBB : 114.04 (+0.52%)
XBI : 87.50 (+0.33%)
SBIO : 37.46 (+1.05%)
EW : 244.37 (+0.33%)
GWPH : 101.92 (-1.58%)
FOMX : 3.37 (-0.88%)
CRSP : 68.67 (+0.31%)
ARKG : 33.12 (+0.88%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 53.16 (+0.45%)
IBB : 114.04 (+0.52%)
XBI : 87.50 (+0.33%)
CELG : 107.64 (-0.45%)
GILD : 65.13 (+0.20%)
BIIB : 287.76 (+0.82%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 53.16 (+0.45%)
IBB : 114.04 (+0.52%)
XBI : 87.50 (+0.33%)
INCY : 89.31 (+1.56%)
VRTX : 215.13 (+0.06%)
AMGN : 224.59 (+0.04%)
Amgen to Buy Celgene's Otezla: 5 ETF Drugs

Amgen agreed to buy psoriasis and psoriatic arthritis drug Otezla from Celgene for $13.4 billion in cash.

NVS : 90.63 (+0.25%)
BMY : 55.62 (-1.52%)
BBH : 136.11 (+0.44%)
PJP : 61.73 (+0.02%)
IBB : 114.04 (+0.52%)
PBE : 53.16 (+0.45%)
CELG : 107.64 (-0.45%)
AMGN : 224.59 (+0.04%)
IEIH : 26.80 (+0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade IBB with:

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

2nd Resistance Point 114.98
1st Resistance Point 114.21
Last Price 114.12
1st Support Level 112.25
2nd Support Level 111.06

See More

52-Week High 116.25
Last Price 114.12
Fibonacci 61.8% 105.84
Fibonacci 50% 102.63
Fibonacci 38.2% 99.42
52-Week Low 89.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar